Delivery Order SPE2DR25D3104-SPE2DR26FE9AS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents, valued at $1,269.91. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by October 28, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child order under AmerisourceBergen's substantial Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,934.20 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 17, 2025, with performance taking place at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $12,107.97 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. This firm fixed price, competitively awarded contract was executed on November 12, 2025, with an ultimate completion date of November 13, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $3,017.66 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. The contract, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, operates under firm fixed price terms with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its Corporate Office location. This...
- The Defense Logistics Agency awarded a $15,037.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. The contract, awarded on November 28, 2025, with an ultimate completion date of December 1, 2025, represents a non-competed delivery order under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $22,966.57 delivery order for Vivitrol 380 mg vial-diluents, with a completion date of August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger pharmaceutical supply agreements with DLA. The pharmaceutical products will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $2,110.14 delivery order to AmerisourceBergen Drug Corp for VIVITROL 380 mg vial-diluents on December 3, 2025, with completion scheduled for December 4, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award is issued from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $10,293.12 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. This is a firm fixed-price delivery order with an ultimate completion date of November 25, 2025. The award was made on a competitive basis with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,730.90 on October 27, 2025, for the supply of Vivitrol 380 mg vial-diluents. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 28, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $6,330.42 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. This non-competitive delivery order, issued on November 24, 2025, represents a firm fixed-price transaction with an ultimate completion date of November 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order through its corporate office location. This...
- SPE2DR25D3104Indefinite Delivery Contract
- SPE2DR25D3104-SPE2DR26FE9ASDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,355.40 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. This firm fixed-price delivery order, issued on December 12, 2025, with an ultimate completion date of December 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through competitive procedures with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, supplying a comprehensive portfolio of medications and medical supplies to support military and veteran healthcare systems. Vivitrol (naltrexone) is an FDA-approved medication used for the treatment of alcohol and opioid use disorders, making this procurement consistent with the Department of Defense's healthcare support mission. The delivery order fulfills AmerisourceBergen's role under its broader $999,999,999.00 prime vendor contract with DLA Troop Support Medical, which extends through December 2026 and enables the company to supply pharmaceutical products and medical commodities globally to support military healthcare programs, the Defense Health Agency, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.4k | 12/11/25 |